3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
20
Myelodysplastic Syndromes
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia
7
Myeloproliferative Disorders
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Leukemia, Myelomonocytic, Chronic
5
Hodgkin Disease
5
Anemia, Refractory, with Excess of Blasts
5
Multiple Myeloma
4
Graft vs Host Disease
4
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Congenital Abnormalities
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Primary Myelofibrosis
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myelodysplastic-Myeloproliferative Diseases
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Interventions
Specimen Handling
51
Carboplatin
49
pembrolizumab
45
Magnetic Resonance Spectroscopy
43
Pemetrexed
39
Cisplatin
34
Paclitaxel
24
durvalumab
23
osimertinib
20
Nivolumab
19
Gemcitabine
19
Radiosurgery
17
Docetaxel
17
atezolizumab
14
Taxes
12
Radiotherapy
12
Immunoglobulin G
12
Disulfides
12
130-nm albumin-bound paclitaxel
12
Etoposide
11
Educational Status
11
Biopsy
11
Radiation
10
Drug Therapy
10
Blood Specimen Collection
10
Platinum
9
Early Intervention, Educational
9
Cetuximab
9
Methods
8
Bevacizumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Busulfan
×
90 days
×
Clear all
No trials found.